Welcome to our dedicated page for Amerisafe SEC filings (Ticker: AMSF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reserve triangles, actuarial footnotes, and exposure-by-class tables make Amerisafe’s disclosures challenging even for seasoned insurance analysts. If you have ever spent hours hunting through a 200-page filing just to confirm loss-reserve development, you know the pain.
Stock Titan solves this by pairing every document with AI-powered summaries that translate statutory jargon into plain English. Need the Amerisafe insider trading Form 4 transactions? Our platform pulls them the moment they hit EDGAR and highlights patterns in executive stock movements. Curious about an Amerisafe quarterly earnings report 10-Q filing? The AI extracts combined ratios, premium growth, and reserve changes, delivering context in seconds. From Amerisafe Form 4 insider transactions real-time to the full stack of 8-K, 10-K, S-4, and DEF 14A reports, coverage is continuous and complete.
Common investor questions are answered right on the page: How are loss reserves trending? Which industries drive premium growth? What does the latest Amerisafe proxy statement executive compensation reveal about underwriting incentives? You’ll also find quick links to an Amerisafe annual report 10-K simplified section, an Amerisafe earnings report filing analysis, and an understanding Amerisafe SEC documents with AI guide. Material updates? See the Amerisafe 8-K material events explained feed for instant insight.
Whether you’re monitoring solvency metrics, sizing catastrophe exposure, or watching an Amerisafe executive stock transactions Form 4, Stock Titan delivers the information you need, when you need it—no actuarial degree required.
Intellia Therapeutics, Inc. (NTLA) – Form 4 insider filing
EVP & CFO Edward J. Dulac III executed an automatic, non-volitional sale of 7,462 common shares on 23 Jul 2025 at $14.02 per share. The disposition was a mandatory “sell-to-cover” to satisfy federal and state tax-withholding obligations triggered by the vesting of RSUs on 22 Jul 2025.
Post-transaction, Dulac directly owns 106,062 NTLA shares; no indirect holdings or derivative security changes were reported. No options were exercised or granted, and the filing does not disclose any additional share sales or purchases.
The event does not materially alter management’s economic exposure to the company and should be viewed as administrative rather than discretionary trading activity.
AMERISAFE, Inc. (AMSF) filed an 8-K on 24-Jul-2025 to disclose that its Board has reauthorized a share-repurchase program of up to $25.0 million. The new authorization replaces the prior program and carries no expiration date. Repurchases may be executed in the open market or through Rule 10b5-1 trading plans and will be funded with available capital. The Board retains full discretion to modify, suspend, increase or terminate the program at any time, based on market conditions and regulatory factors. The filing contains no earnings data and does not obligate the company to repurchase any specific amount of shares.
Medpace Holdings, Inc. (MEDP) – Form 144 filing discloses a planned sale of 41,801 common shares through Fidelity Brokerage Services on or about 07/24/2025. The shares carry an aggregate market value of US$18.94 million, implying an estimated price of roughly US$453 per share. With 28.09 million shares outstanding, the proposed disposition equals approximately 0.15 % of total shares, a relatively small portion of the float.
No other MEDP securities were sold by the same account during the past three months, and the filer certifies the absence of undisclosed adverse information. The document does not reveal the seller’s name, relationship to the company, or whether the trade is under a Rule 10b5-1 plan, leaving limited insight into the motivation behind the sale.
FAQ
What is the current stock price of Amerisafe (AMSF)?
What is the market cap of Amerisafe (AMSF)?
What is the primary business focus of Amerisafe Inc?
Which industries does Amerisafe primarily serve?
How does Amerisafe generate its revenue?
What makes Amerisafe’s underwriting process unique?
How is Amerisafe distributed to reach its target market?
How does the company maintain compliance within high-risk sectors?
In what ways does Amerisafe differentiate itself from other insurance providers?
